MEDICAL CARE CORPORATION
Medtech · Private
Digital cognitive biomarkers using Hierarchical Bayesian Cognitive Processing models to predict amyloid positivity from memory test data
- Grants
- $1.9M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 9
- 3 granted · 6 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Predicting Impending Cognitive Decline in Cognitively Normal Individuals | $129,734 | |
| Federal grant | Department of Health and Human Services · Phase II · Predicting Impending Cognitive Decline in Cognitively Normal Individuals | $837,630 | |
| Federal grant | Department of Health and Human Services · Phase II · Predicting Impending Cognitive Decline in Cognitively Normal Individuals | $304,325 | |
| Federal grant | Department of Health and Human Services · Phase II · Predicting Impending Cognitive Decline in Cognitively Normal Individuals | $180,552 | |
| Federal grant | Department of Health and Human Services · Phase I · Validating Digital Cognitive Biomarkers to Advance Alzheimer's Drug Development | $455,341 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1770 | YENOS ANALYTICAL, LLC | — | — |
| 1771 | River Sonic Solutions LLC | — | — |
| 1772 | REKOVAR INC. | — | — |
| 1773 | MEDICAL CARE CORPORATION | — | — |
| 1774 | ACTIVE LIFE SCIENTIFIC, INC. | — | $2.7M |
| 1775 | WILD DOG PHYSICS, LLC | — | — |
| 1776 | ENDOBETES, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Classifying Individuals Using Finite Mixture Markov Modelling And Test Trials With Accounting For Item Positiongranted
- Assessing Cognition Using Item-recall Trials With Accounting For Item Positiongranted
- Systems And Methods For Assessing Human Cognition, Including A Quantitative Approach To Assessing Executive Functiongranted
- Assessing Variation In Clinical Response Data Based On A Computational Representation Of Neural Or Psychological Processes Underlying Performance On A Brain Function Testapplication
- Brain Condition Assessmentapplication
- Non-natural Pattern Identification For Cognitive Assessmentapplication
- Cognitive Function Indexapplication
- Systems And Methods For Assessing Human Cognition, Including A Quantitative Approach To Assessing Executive Functionapplication
- Assessing Cognition Using Item-recall Trials With Accounting For Item Positionapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.